IPA Updating Existing DHDSP Pharmacy Portfolio Products to Focus on Health Equity

The Centers for Disease Control and Prevention is forecasting an opportunity to update existing DHDSP pharmacy portfolio products with a new focus on health equity, aiming to enhance the alignment of pharmaceutical services with equitable health outcomes. This initiative seeks to refine current tools, resources, or frameworks to better address disparities in access, utilization, and outcomes related to pharmacy services among underserved and marginalized populations. The effort is classified under NAICS code 541618, indicating it involves other scientific and technical consulting services, and will require expertise in pharmacy practice, public health equity, data analysis, and community engagement to effectively restructure or augment existing products. The point of contact for this opportunity is Joanna Elmi, serving as the Program Point of Contact, with the contracting officer position yet to be filled. All communications and inquiries should be directed to zft6@cdc.gov. The forecast was posted on May 25, 2026, and while no solicitation number or set-aside details are currently available, stakeholders should anticipate a future competitive procurement process. The place of performance and organizational specifics remain undetermined, suggesting flexibility in execution but requiring proposers to be prepared for potential national or multi-jurisdictional implementation. Interested parties are advised to monitor the official HHS OSDBU portal for updates regarding the formal solicitation release.